CASTLE BIOSCIENCES INC's ticker is CSTL and the CUSIP is 14843C105. A total of 166 filers reported holding CASTLE BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $460,438 | -87.1% | 27,261 | -82.7% | 0.00% | -100.0% |
| Q2 2023 | $3,574,355 | 0.0% | 157,322 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $3,574,355 | -4.5% | 157,322 | -1.1% | 0.00% | 0.0% |
| Q4 2022 | $3,744,345 | -99.9% | 159,063 | +8.7% | 0.00% | 0.0% |
| Q3 2022 | $3,816,702,000 | +10.6% | 146,346 | -6.9% | 0.00% | 0.0% |
| Q2 2022 | $3,449,486,000 | -56.8% | 157,152 | -11.6% | 0.00% | -33.3% |
| Q1 2022 | $7,977,499,000 | -0.6% | 177,831 | -5.0% | 0.00% | 0.0% |
| Q4 2021 | $8,027,106,000 | -32.4% | 187,243 | +4.8% | 0.00% | -40.0% |
| Q3 2021 | $11,880,558,000 | -13.3% | 178,655 | -4.4% | 0.01% | -16.7% |
| Q2 2021 | $13,698,558,000 | +3.4% | 186,807 | -3.5% | 0.01% | 0.0% |
| Q1 2021 | $13,252,350,000 | +3.8% | 193,578 | +1.8% | 0.01% | 0.0% |
| Q4 2020 | $12,769,782,000 | -4.2% | 190,168 | -26.6% | 0.01% | -14.3% |
| Q3 2020 | $13,332,598,000 | +115.6% | 259,137 | +57.9% | 0.01% | +75.0% |
| Q2 2020 | $6,184,138,000 | +33.3% | 164,079 | +5.5% | 0.00% | +33.3% |
| Q1 2020 | $4,637,870,000 | – | 155,581 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 33,626 | $567,943 | 77.21% |
| Millrace Asset Group, Inc. | 77,315 | $1,306 | 1.61% |
| Granahan Investment Management | 2,487,673 | $42,016,797 | 1.50% |
| Parkman Healthcare Partners LLC | 224,592 | $3,793,359 | 0.70% |
| PERKINS CAPITAL MANAGEMENT INC | 29,160 | $493 | 0.49% |
| Capital Impact Advisors, LLC | 16,554 | $279,597 | 0.47% |
| Soleus Capital Management, L.P. | 283,500 | $4,788,315 | 0.44% |
| Portolan Capital Management | 253,028 | $4,273,643 | 0.40% |
| Numerai GP LLC | 68,163 | $1,151,273 | 0.38% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 946,620 | $15,988,412 | 0.35% |